CDC42 and ovarian serous adenocarcinoma: Further investigation into the mechanism by which high grade serous ovarian cancer cells experience compression and control downstream effectors of CDC42 will be an important step for the development of targeted therapies that prevent this apparent feed forward mechanism of stress induced proliferation and drug resistance.